RecallRadar

FDA Drug recall D-0839-2026

Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made…

On 2026-09-09 the FDA classified a Class II recall of Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made… by Mylan Pharmaceuticals, citing failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0839-2026
ClassificationClass II
Statusongoing
Initiated2026-08-17
Published2026-09-09
Last updated2026-09-23 05:30 UTC
CompanyMylan Pharmaceuticals
DistributionUS

Product

Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 0378-5186-93.

Reason

Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria

Identifiers

ndc0378-5185-93
ndc0378-5186-93
code_infoLot #: 3225272, Exp. September 30, 2026

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-23 05:30 UTC. Current status: ongoing.

Other recalls by Mylan Pharmaceuticals

All Mylan Pharmaceuticals recalls

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0839-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.